J. White
11 Papers
1 Citations
J. White is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 11 publications.
Chat about Author
Papers
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases
Mohammed Abdulhaleem,Hannah Johnston,Ralph B. D'Agostino,C.M. Lanier,Michael C. LeCompte,Christina K. Cramer,Jimmy Ruiz,Thomas Lycan,Hui-Wen Lo,Kuonosuke Watabe,Stacey S O'Neill,C. Whitlow,J. White,Stephen B. Tatter,Adrian W. Laxton,Jing Su,Michael D. Chan +16 more
TL;DR: The clinical outcomes of 80 consecutive lung cancer patients treated with concurrent immune checkpoint inhibitors and stereotactic radiosurgery were compared to 235 in the historical control cohort, suggesting that brain metastasis patients may benefit from concurrent use of immunotherapy with SRS.
24
Outcomes and principles of patient selection for laser interstitial thermal therapy (LITT) for metastatic brain tumor management: a multi-site, institutional case series.
Cecile Riviere-Cazaux,Archis R. Bhandarkar,Masum Rahman,Clark Renjun Zheng,Megan M J Bauman,Ryan M. Naylor,Jamie J. Van Gompel,Richard S. Zimmerman,J. White,Ian F. Parney,Kaisorn L. Chaichana,Kai J. Miller,Vance T. Lehman,Timothy J. Kaufmann,Terry C. Burns +14 more
TL;DR: Laser interstitial thermal therapy (LITT) is an emerging treatment modality for both primary brain tumors and metastases as mentioned in this paper and has been shown to achieve local control of the lesion in most patients with metastatic tumors or radiation necrosis.
7
Long term survivors of stereotactic radiosurgery for brain metastases: do distant brain failures reach a plateau and what factors are associated with a brain metastasis velocity of zero?
C.M. Lanier,John B. Pearce,Scott Isom,Fei Xing,Heng-Wei Lo,C. Whitlow,Justin Ruiz,J. White,Adrian W. Laxton,Stephen B. Tatter,Christina K. Cramer,Mel D. Chan +11 more
TL;DR: In this article , a single-institution retrospective study of 300 patients treated with stereotactic radiosurgery (SRS) from 2001 to 2019 for brain metastases without prior whole brain radiotherapy (WBRT) who survived greater than two years after first SRS was presented.
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery
Niema Razavian,Corbin A. Helis,Adrian W. Laxton,Stephen B. Tatter,J. Daniel Bourland,Ryan T. Mott,Glenn J. Lesser,Roy E. Strowd,J. White,Michael D. Chan,Christina K. Cramer +10 more
TL;DR: Stereotactic radiosurgery is a safe and effective treatment option for radiographic RIMs, WHO grade I R IMs, or lesions treated in the upfront setting, and WHO grade II lesions and recurrent lesions are at increased risk for disease progression.
2
Five-year survivors from brain metastases treated with stereotactic radiosurgery: Biology, improving treatments, or just plain luck?
John B. Pearce,Fu-Chieh Hsu,C.M. Lanier,Christina K. Cramer,Justin Ruiz,Hui-Wen Lo,Fei Xing,W Y Li,C. Whitlow,J. White,Stephen B. Tatter,Adrian W. Laxton,Mel D. Chan +12 more
TL;DR: In this paper , a single institution retrospective review was performed to identify 5-year survivors of brain metastases who have received stereotactic radiosurgery (SRS). Electronic medical records were queried to characterize this population based on clinical, demographic and treatment data.
1